Structure-activity studies of the Phe4 residue of nociceptin(1-13)-NH2:: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor

被引:40
作者
Guerrini, R
Caló, G
Bigoni, R
Rizzi, D
Rizzi, A
Zucchini, M
Varani, K
Hashiba, E
Lambert, DG
Toth, G
Borea, PA
Salvadori, S
Regoli, D
机构
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy
[4] Univ Leicester, Leicester Royal Infirm, Dept Anaesthesia Crit Care & Pain Management, Leicester LE1 5WW, Leics, England
[5] Biol Res Ctr, Isotope Lab, Inst Biochem, H-6701 Szeged, Hungary
关键词
D O I
10.1021/jm010221v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A total of 32 compounds was prepared to investigate the functional role of Phe(4) in NC(1-13)NH2, the minimal sequence maintaining the same activity as the natural peptide nociceptin. These compounds could be divided into three series in which Phe(4) was replaced with residues that would (i) alter aromaticity or side chain length, (ii) introduce steric constraint, and (iii) modify the phenyl ring. Compounds were tested for biological activity as (a) inhibitors of the electrically stimulated contraction of the mouse vas deferens; (b) competitors of the binding of [H-3]-NC-NH2 to mouse brain membranes; and (c) inhibitors of forskolin-stimulated cAMP accumulation in CHO cells expressing the recombinant human OP4 receptor. Results indicate that all compounds of the first and second series were inactive or very weak with the exception of [N(CH3)Phe(4)]NC(1-13)-NH2, which was only 3-fold less potent than NC(1-13)-NH2.Compounds of the third series showed higher, equal, or lower potencies than NC(1-13)-NH2. In particular, [(pF)Phe(4)]NC(1-13)-NH2 (pF) and [(pNO(2))Phe(4)]NC(1-13)-NH2 (pNO(2)) were more active than NC(1-13)-NH2 by a factor of 5. In the mVD, these compounds showed the following order of potency: (pF) = (pNO(2)) greater than or equal to (pCN) > (pCl) > (pBr) > (pI) = (pCF(3)) = (pOCH(3)) > (pCH(3)) > (PNH2) = (pOH). (oF) and especially (mF) maintained high potencies but were less active than (pF), Similar orders of potency were observed in binding competition and cAMP accumulation studies. There was a strong (r(2) greater than or equal to 0.66) correlation between data observed in these assays. Biological activity data of compounds of the third series were plotted against some Hansch parameters that are currently used to quantify physicochemical features of the substituents. In the three biological assays agonist potency/affinity positively correlates with the electron withdrawal properties of the groups in the p-position of Phe(4) and inversely with their size.
引用
收藏
页码:3956 / 3964
页数:9
相关论文
共 37 条
[1]  
Berger H, 2000, J PHARMACOL EXP THER, V294, P428
[2]   Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies [J].
Bigoni, R ;
Giuliani, S ;
Calo, G ;
Rizzi, A ;
Guerrini, R ;
Salvadori, S ;
Regoli, D ;
Maggi, CA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (03) :160-167
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   The mouse vas deferens: A pharmacological preparation sensitive to nociceptin [J].
Calo, G ;
Rizzi, A ;
Bogoni, G ;
Neugebauer, V ;
Salvadori, S ;
Guerrini, R ;
Bianchi, C ;
Regoli, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 311 (01) :R3-R5
[5]   Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist [J].
Calo', G ;
Guerrini, R ;
Bigoni, R ;
Rizzi, A ;
Bianchi, C ;
Regoli, D ;
Salvadori, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3360-3366
[6]   Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist [J].
Calo', G ;
Guerrini, R ;
Bigoni, R ;
Rizzi, A ;
Marzola, G ;
Okawa, H ;
Bianchi, C ;
Lambert, DG ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (06) :1183-1193
[7]   Pharmacology of nociceptin and its receptor: a novel therapeutic target [J].
Calo, G ;
Guerrini, R ;
Rizzi, A ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (07) :1261-1283
[8]   1-HYDROXY-7-AZABENZOTRIAZOLE - AN EFFICIENT PEPTIDE COUPLING ADDITIVE [J].
CARPINO, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (10) :4397-4398
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A [J].
Guerrini, R ;
Calo, G ;
Rizzi, A ;
Bigoni, R ;
Rizzi, D ;
Regoli, D ;
Salvadori, S .
PEPTIDES, 2000, 21 (07) :923-933